Shanghai RAAS Blood Products Co., a seller of treatments made from human blood plasma, rallied to new highs at a time when many of the country’s blue-chip firms were sinking. China’s surging demand for plasma therapies, medicines made from blood components that are used during surgeries or for disorders like hemophilia, a condition in which blood doesn’t...